Free Trial

This company has been marked as potentially delisted and may not be actively trading.

NASDAQ:ACER

Acer Therapeutics (ACER) Stock Price, News & Analysis

Acer Therapeutics logo

About Acer Therapeutics Stock (NASDAQ:ACER)

Advanced Chart

Key Stats

Today's Range
$0.66
$0.85
50-Day Range
$0.66
$0.90
52-Week Range
$0.55
$4.56
Volume
574,675 shs
Average Volume
N/A
Market Capitalization
$16.15 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive ACER Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Acer Therapeutics and its competitors with MarketBeat's FREE daily newsletter.

ACER Stock News Headlines

Trump’s biggest move, misreported
The media and financial pundits are all misreading Trump’s actions. They think Trump wants to make Canada the 51st state because he’s desperate for critical minerals… They think his involvement in Ukraine is just another resource grab… They think his tariffs will wreck the economy… But they’re all missing the bigger picture.
Anumana Appoints Harry S. Palmin as CFO
See More Headlines

ACER Stock Analysis - Frequently Asked Questions

Acer Therapeutics Inc. (NASDAQ:ACER) announced its quarterly earnings results on Friday, November, 19th. The biopharmaceutical company reported ($0.23) earnings per share for the quarter, topping analysts' consensus estimates of ($0.28) by $0.05.

Acer Therapeutics subsidiaries include Opexa Therapeutics Inc..

Based on aggregate information from My MarketBeat watchlists, some other companies that Acer Therapeutics investors own include NVIDIA (NVDA), Broadcom (AVGO), CymaBay Therapeutics (CBAY), GE Aerospace (GE), Meta Platforms (META), Adobe (ADBE) and Novo Nordisk A/S (NVO).

Company Calendar

Last Earnings
11/19/2021
Today
7/18/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Pharmaceutical preparations
Sub-Industry
N/A
Current Symbol
NASDAQ:ACER
CIK
1069308
Employees
30
Year Founded
2013

Profitability

EPS (Trailing Twelve Months)
N/A
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
N/A
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
N/A
Return on Assets
N/A

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
N/A
Quick Ratio
N/A

Sales & Book Value

Annual Sales
N/A
Price / Sales
N/A
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
N/A
Price / Book
N/A

Miscellaneous

Outstanding Shares
24,460,000
Free Float
19,522,000
Market Cap
$16.15 million
Optionable
Not Optionable
Beta
N/A

Social Links

(Almost)  Everything You Need To Know About The EV Market Cover

Looking to profit from the electric vehicle mega-trend? Enter your email address and we'll send you our list of which EV stocks show the most long-term potential.

Get This Free Report

This page (NASDAQ:ACER) was last updated on 7/18/2025 by MarketBeat.com Staff
From Our Partners